BEDFORD, Mass., March 10 /PRNewswire/ --Toxikon Corporation, a preclinical contract testing lab, invites quality assurance, research and development and regulatory professionals to Bedford, Massachusetts April 20 for an international symposium on extractables and leachables testing.
The seminar will provide tips on how to design an extractables and leachables study and reveal winning strategies for quality control, risk assessment and material selection.
The full day conference is $249 per person and includes the cost of breakfast, lunch and refreshments. Registration is on a first-come, first-served basis and will be limited to 40 people.
Toxikon Corporation is an ISO 17025-certified global Contract Research Organization (CRO) that conducts compliance and safety testing for the medical device and biopharmaceutical industries. With more than 30 years of experience, Toxikon provides testing services to meet FDA/ISO/ICH, OECD, USP and Japan’s MHLW standards. Testing services include in-vivo toxicology, genetic toxicology, microbiology, and specialized analytical chemistry to meet GMP/GLP requirements.
Toxikon Corporation
